Skip to main content

Table 1 Demographic characteristics of included studies

From: Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review

Authors, year Study Design Study Setting N Age Sex Co-morbidities Stage of cancer Location of cancer Type of cancer treatment Complications post-surgery Dysphagia Assessment for Outcomes
Okumura et al., 2016 [37] Case Control Study (CCS) Toyoma University Hospital, Japan 26 CG; Mean 65.9 +/− 9.7 yrs.
TG: 68+/−5.1 yrs.
CG: 13/1 M:F
TG: 12 M
NI TNM Classification (JES) -I/II CG: 11 (78.6%) TG: 5 (41.7%) -III/IV CG: 3 (21.4%) TG: 7 (58.3%) TNM Classification (UICC) - I/II CG:12 (85.7%) TG: 8 (66.7%) -III/IV CG: 2 (14.3%) TG: 4 (33.3%) Thoracic “Oesophagectomy” 5 participants: neoadjuvant chemotherapy CG:
RLNP (n = 4)
AP (n = 3)
AL (n = 2)
TG:
RLNP(n = 2),
AP (n = 3)
AL (n = 2)
Non-validated:
1. Functional Outcomes Assessment Measure of Swallowing (FOAMS) Scale.
2 Measured relevant biomechanical positions and volumes on x-axis and y-axis plots from VFSS images
Tsubosa et al., 2005 [69] Case Series (CS) Shizuoka Cancer Hospital Rehabilitation Dept., Japan 9 Mean 57.8 +/− 9 yrs. 9 M Cases 1: Hx of RTC; 2: old age; 3: Hx of stroke and abnormal shape of epiglottis; and 4: abnormal shape of epiglottis. The remaining 5 cases had no relevant co-morbidities that may affect swallowing NI Thoracic “Oesophagectomy” RLNP (n = 5. 1 of which was bilateral resulting in severe AP) Non-validated:
VFSS rating tool suggested by Logemann, 1998
Takatsu et al., 2020 [70] Retrospective case control study Aichi Cancer Centre Hospital, Japan 276 CG; median 68 (IQR 64–74)
TG; 69 (IQR 62–73)
CG: 91/18 M:F
TG: 142/25 M:F
NI TNM Classification (UICC)
-I/II CG: 49 (45%)
TG: 56 (45%)
-III/IV CG: 60 (55%)
TG: 91 (55%)
Thoracic CG: Neoadjuvant therapies: 87 (80%)
Thoracoscopic oesophagectomy
Open Oesophagectomy
Cervical anastomosis
TG: Neoadjuvant therapies: 133 (80%)
Thoracoscopic oesophagectomy
Open oesophagectomy
Cervical anastomosis
CG:
RLNP 22 (20%)
Pneumonia 25 (23%)
AL: 8 (7%)
TG:
RLNP 34 (20%)
Pneumonia 39 (23%)
AL 22 (13%)
1. Start of oral intake
2. Length of oral intake rehabilitation
3. Length of postoperative stay
  1. Key: Std Dev Standard Deviation, NI No Information provided, RLNP Recurrent Laryngeal Nerve Palsy, AP Aspiration Pneumonia, VFSS Videofluoroscopy, CG control group, TG treatment group, JES Japan Esophageal Society, UICC Union for International Cancer Control, Yrs years, AL Anastomatic Leak, Hx history, RTC radiotherapy for tongue cancer